MDM2 and Glucose intolerance: Since genetic disruption or pharmacological inhibition of MDM2 led to p53 activation in pancreatic β-cells, we next explored whether the inactivation of p53 could reverse glucose intolerance and defective GSIS in β-MDM2KO mice.